ICA-121431 is a potent, selective inhibitor of the human Nav1.3 and Nav1.1 voltage gated sodium channels (IC50 = 19 nM) with little or no activity against human Nav1.5 or Nav1.7 channels. Voltage-gated sodium channels initiate action potentials in brain neurons, and sodium channel blockers are used in therapy of epilepsy.

Product information

CAS Number: 313254-51-2

Molecular Weight: 449.55

Formula: C23H19N3O3S2

Chemical Name: 2,2-diphenyl-N-{4-[(1,3-thiazol-2-yl)sulfamoyl]phenyl}acetamide

Smiles: O=C(NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1)C(C1=CC=CC=C1)C1=CC=CC=C1

InChiKey: URSQNPPONHUJDL-UHFFFAOYSA-N

InChi: InChI=1S/C23H19N3O3S2/c27-22(21(17-7-3-1-4-8-17)18-9-5-2-6-10-18)25-19-11-13-20(14-12-19)31(28,29)26-23-24-15-16-30-23/h1-16,21H,(H,24,26)(H,25,27)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.